Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Bagno A Ripoli – page 2

14 clinical trials in Bagno A Ripoli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Bagno A Ripoli at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

14 trials in Bagno A Ripoli

Open in trial search

Lung disorder

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF

Lung disorder

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Oslo University Hospital HF

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Bagno A Ripoli

What the registry says about research in the country

01 HIV Management Studies

Innovative research exploring two-drug regimens for HIV-1 treatment, focusing on effectiveness of early switching strategies in virologically suppressed patients.

  • Dolutegravir/Lamivudine evaluation
  • Women-specific HIV treatment optimization
  • Virological suppression maintenance

These trials aim to simplify treatment while maintaining optimal viral control.

02 Cardiovascular and Metabolic Research

Studies investigating cardiovascular outcomes in type 2 diabetes patients, exploring preventive strategies using established medications in new combinations.

  • Diabetes cardiovascular prevention
  • Colchicine and aspirin therapy
  • Risk reduction strategies

Focus on preventing adverse cardiovascular events in high-risk populations.

03 Oncology Studies

Advanced research in breast cancer and melanoma treatment, evaluating targeted therapies and comparing treatment approaches.

  • Early-stage breast cancer therapy
  • Colorectal cancer treatments
  • Targeted melanoma interventions

Emphasis on personalized treatment strategies for different cancer types.

04 Renal Disease Research

Innovative studies in end-stage kidney disease treatment, testing new dialysis solutions and cardiovascular outcomes.

  • Peritoneal dialysis optimization
  • Cardiovascular complications
  • Novel therapeutic approaches

Focus on improving dialysis outcomes and patient quality of life.

05 COVID-19 Research

Critical investigations into SARS-CoV-2 treatment options, evaluating novel therapeutic approaches for varying disease severities.

  • Moderate COVID-19 management
  • Severe disease interventions
  • Immunocompromised patient care

Emphasis on developing effective treatment protocols for different patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.